Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XYLB | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | ZEB2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | FOXI2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | NCOR1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | OTC | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | STRA13 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | APCDD1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | GRAP2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | CTIF | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | SLC2A4RG | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |